Global Biologics Fill and Finish Services

Biologics Fill and Finish Services Comprehensive Study by Type (Liquid, Lyophilized), Application (Preclinical, Clinical, Commercial), Organization Size (Small-sized, Mid -sized, Large / very large), Filled Types (Peptides / proteins, Antibodies, Vaccines, Cell therapies, Gene therapies, Viral products, Oligonucleotides), Diseases (Cancer, Infectious diseases, Autoimmune diseases, Cardiovascular diseases, Other indications) Players and Region - Global Market Outlook to 2026

Biologics Fill and Finish Services Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Biologics Fill and Finish Services Market Scope?
Biologics account for the vast majority of top-selling drugs and are currently one of the pharmaceutical industry's fastest-growing segments. Fill/finish, in particular, is the final step in the manufacturing process and is regarded as one of the most critical stages of drug product manufacturing. Biologics drug products necessitate special fill/finish procedures and equipment to ensure product integrity and safety. Because this operation is heavily outsourced, the rise in biologics demand has resulted in an equal demand for flexible aseptic fill/finish technologies. To meet the anticipated future demand for biologics fill/finish services in the American and European markets, contract service providers in these regions have made significant investments in accruing additional capacity for drug product manufacturing and fill/finish, resulting in a surge in demand for Biologics Fill and Finish Services.

The Biologics Fill and Finish Services market study is being classified by Type (Liquid and Lyophilized), by Application (Preclinical, Clinical and Commercial) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies Analysts at AMA predicts that Players from Germany will contribute to the maximum growth of Global Biologics Fill and Finish Services market throughout the predicted period.

Becton, Dickson, and Company (United States), Syntegon Technology GmbH (Germany), IMA Industria Macchine Automatiche S.p.A. (Italy), Stevanato Group (Italy), Groninger & Co.gmbh (Germany), Gerresheimer AG (Germany), SGD Pharma (France), Bausch Advanced Technologies Group (United States), Vanrx Pharmasystems Inc. (Canada) and Maquinaria Industrial Dara, SL (Spain) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are West Pharmaceutical Services, Inc. (United States), OPTIMA packaging group GmbH (Germany) and Bausch+Strobel (Germany).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Biologics Fill and Finish Services market by Type, Application and Region.

On the basis of geography, the market of Biologics Fill and Finish Services has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • Increasing existing capabilities as well as setting-up of new facilities by the service providers.

Market Drivers
  • Rising technological advancements in fill-finish manufacturing processes
  • Growth of the biopharmaceutical industry
  • Rising adoption of prefilled syringes for parenteral dosage forms

Opportunities
  • Increased Adoption of Technologically Advanced Fill / Finish Solutions Triggers Growth

Restraints
  • High costs associated with isolators/RABS

Challenges
  • Challenges associated with maintaining sterility in fill-finish manufacturing operations


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Biologics Fill and Finish Services Provider, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Liquid
  • Lyophilized
By Application
  • Preclinical
  • Clinical
  • Commercial
By Organization Size
  • Small-sized
  • Mid -sized
  • Large / very large

By Filled Types
  • Peptides / proteins
  • Antibodies
  • Vaccines
  • Cell therapies
  • Gene therapies
  • Viral products
  • Oligonucleotides

By Diseases
  • Cancer
  • Infectious diseases
  • Autoimmune diseases
  • Cardiovascular diseases
  • Other indications

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising technological advancements in fill-finish manufacturing processes
      • 3.2.2. Growth of the biopharmaceutical industry
      • 3.2.3. Rising adoption of prefilled syringes for parenteral dosage forms
    • 3.3. Market Challenges
      • 3.3.1. Challenges associated with maintaining sterility in fill-finish manufacturing operations
    • 3.4. Market Trends
      • 3.4.1. Increasing existing capabilities as well as setting-up of new facilities by the service providers.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biologics Fill and Finish Services, by Type, Application, Organization Size, Filled Types, Diseases and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Biologics Fill and Finish Services (Value)
      • 5.2.1. Global Biologics Fill and Finish Services by: Type (Value)
        • 5.2.1.1. Liquid
        • 5.2.1.2. Lyophilized
      • 5.2.2. Global Biologics Fill and Finish Services by: Application (Value)
        • 5.2.2.1. Preclinical
        • 5.2.2.2. Clinical
        • 5.2.2.3. Commercial
      • 5.2.3. Global Biologics Fill and Finish Services by: Organization Size (Value)
        • 5.2.3.1. Small-sized
        • 5.2.3.2. Mid -sized
        • 5.2.3.3. Large / very large
      • 5.2.4. Global Biologics Fill and Finish Services by: Filled Types (Value)
        • 5.2.4.1. Peptides / proteins
        • 5.2.4.2. Antibodies
        • 5.2.4.3. Vaccines
        • 5.2.4.4. Cell therapies
        • 5.2.4.5. Gene therapies
        • 5.2.4.6. Viral products
        • 5.2.4.7. Oligonucleotides
      • 5.2.5. Global Biologics Fill and Finish Services by: Diseases (Value)
        • 5.2.5.1. Cancer
        • 5.2.5.2. Infectious diseases
        • 5.2.5.3. Autoimmune diseases
        • 5.2.5.4. Cardiovascular diseases
        • 5.2.5.5. Other indications
      • 5.2.6. Global Biologics Fill and Finish Services Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Biologics Fill and Finish Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton, Dickson, and Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Syntegon Technology GmbH (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. IMA Industria Macchine Automatiche S.p.A. (Italy)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Stevanato Group (Italy)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Groninger & Co.gmbh (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Gerresheimer AG (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. SGD Pharma (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bausch Advanced Technologies Group (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Vanrx Pharmasystems Inc. (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Maquinaria Industrial Dara, SL (Spain)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Biologics Fill and Finish Services Sale, by Type, Application, Organization Size, Filled Types, Diseases and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Biologics Fill and Finish Services (Value)
      • 7.2.1. Global Biologics Fill and Finish Services by: Type (Value)
        • 7.2.1.1. Liquid
        • 7.2.1.2. Lyophilized
      • 7.2.2. Global Biologics Fill and Finish Services by: Application (Value)
        • 7.2.2.1. Preclinical
        • 7.2.2.2. Clinical
        • 7.2.2.3. Commercial
      • 7.2.3. Global Biologics Fill and Finish Services by: Organization Size (Value)
        • 7.2.3.1. Small-sized
        • 7.2.3.2. Mid -sized
        • 7.2.3.3. Large / very large
      • 7.2.4. Global Biologics Fill and Finish Services by: Filled Types (Value)
        • 7.2.4.1. Peptides / proteins
        • 7.2.4.2. Antibodies
        • 7.2.4.3. Vaccines
        • 7.2.4.4. Cell therapies
        • 7.2.4.5. Gene therapies
        • 7.2.4.6. Viral products
        • 7.2.4.7. Oligonucleotides
      • 7.2.5. Global Biologics Fill and Finish Services by: Diseases (Value)
        • 7.2.5.1. Cancer
        • 7.2.5.2. Infectious diseases
        • 7.2.5.3. Autoimmune diseases
        • 7.2.5.4. Cardiovascular diseases
        • 7.2.5.5. Other indications
      • 7.2.6. Global Biologics Fill and Finish Services Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biologics Fill and Finish Services: by Type(USD Million)
  • Table 2. Biologics Fill and Finish Services Liquid , by Region USD Million (2015-2020)
  • Table 3. Biologics Fill and Finish Services Lyophilized , by Region USD Million (2015-2020)
  • Table 4. Biologics Fill and Finish Services: by Application(USD Million)
  • Table 5. Biologics Fill and Finish Services Preclinical , by Region USD Million (2015-2020)
  • Table 6. Biologics Fill and Finish Services Clinical , by Region USD Million (2015-2020)
  • Table 7. Biologics Fill and Finish Services Commercial , by Region USD Million (2015-2020)
  • Table 8. Biologics Fill and Finish Services: by Organization Size(USD Million)
  • Table 9. Biologics Fill and Finish Services Small-sized , by Region USD Million (2015-2020)
  • Table 10. Biologics Fill and Finish Services Mid -sized , by Region USD Million (2015-2020)
  • Table 11. Biologics Fill and Finish Services Large / very large , by Region USD Million (2015-2020)
  • Table 12. Biologics Fill and Finish Services: by Filled Types(USD Million)
  • Table 13. Biologics Fill and Finish Services Peptides / proteins , by Region USD Million (2015-2020)
  • Table 14. Biologics Fill and Finish Services Antibodies , by Region USD Million (2015-2020)
  • Table 15. Biologics Fill and Finish Services Vaccines , by Region USD Million (2015-2020)
  • Table 16. Biologics Fill and Finish Services Cell therapies , by Region USD Million (2015-2020)
  • Table 17. Biologics Fill and Finish Services Gene therapies , by Region USD Million (2015-2020)
  • Table 18. Biologics Fill and Finish Services Viral products , by Region USD Million (2015-2020)
  • Table 19. Biologics Fill and Finish Services Oligonucleotides , by Region USD Million (2015-2020)
  • Table 20. Biologics Fill and Finish Services: by Diseases(USD Million)
  • Table 21. Biologics Fill and Finish Services Cancer , by Region USD Million (2015-2020)
  • Table 22. Biologics Fill and Finish Services Infectious diseases , by Region USD Million (2015-2020)
  • Table 23. Biologics Fill and Finish Services Autoimmune diseases , by Region USD Million (2015-2020)
  • Table 24. Biologics Fill and Finish Services Cardiovascular diseases , by Region USD Million (2015-2020)
  • Table 25. Biologics Fill and Finish Services Other indications , by Region USD Million (2015-2020)
  • Table 26. South America Biologics Fill and Finish Services, by Country USD Million (2015-2020)
  • Table 27. South America Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 28. South America Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 29. South America Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 30. South America Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 31. South America Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 32. Brazil Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 33. Brazil Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 34. Brazil Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 35. Brazil Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 36. Brazil Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 37. Argentina Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 38. Argentina Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 39. Argentina Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 40. Argentina Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 41. Argentina Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 42. Rest of South America Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 43. Rest of South America Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 44. Rest of South America Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 45. Rest of South America Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 46. Rest of South America Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 47. Asia Pacific Biologics Fill and Finish Services, by Country USD Million (2015-2020)
  • Table 48. Asia Pacific Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 49. Asia Pacific Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 50. Asia Pacific Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 51. Asia Pacific Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 52. Asia Pacific Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 53. China Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 54. China Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 55. China Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 56. China Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 57. China Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 58. Japan Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 59. Japan Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 60. Japan Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 61. Japan Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 62. Japan Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 63. India Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 64. India Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 65. India Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 66. India Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 67. India Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 68. South Korea Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 69. South Korea Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 70. South Korea Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 71. South Korea Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 72. South Korea Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 73. Taiwan Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 74. Taiwan Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 75. Taiwan Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 76. Taiwan Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 77. Taiwan Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 78. Australia Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 79. Australia Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 80. Australia Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 81. Australia Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 82. Australia Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 83. Rest of Asia-Pacific Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 84. Rest of Asia-Pacific Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 85. Rest of Asia-Pacific Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 86. Rest of Asia-Pacific Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 87. Rest of Asia-Pacific Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 88. Europe Biologics Fill and Finish Services, by Country USD Million (2015-2020)
  • Table 89. Europe Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 90. Europe Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 91. Europe Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 92. Europe Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 93. Europe Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 94. Germany Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 95. Germany Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 96. Germany Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 97. Germany Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 98. Germany Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 99. France Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 100. France Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 101. France Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 102. France Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 103. France Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 104. Italy Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 105. Italy Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 106. Italy Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 107. Italy Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 108. Italy Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 109. United Kingdom Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 110. United Kingdom Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 111. United Kingdom Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 112. United Kingdom Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 113. United Kingdom Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 114. Netherlands Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 115. Netherlands Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 116. Netherlands Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 117. Netherlands Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 118. Netherlands Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 119. Rest of Europe Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 120. Rest of Europe Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 121. Rest of Europe Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 122. Rest of Europe Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 123. Rest of Europe Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 124. MEA Biologics Fill and Finish Services, by Country USD Million (2015-2020)
  • Table 125. MEA Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 126. MEA Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 127. MEA Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 128. MEA Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 129. MEA Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 130. Middle East Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 131. Middle East Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 132. Middle East Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 133. Middle East Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 134. Middle East Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 135. Africa Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 136. Africa Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 137. Africa Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 138. Africa Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 139. Africa Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 140. North America Biologics Fill and Finish Services, by Country USD Million (2015-2020)
  • Table 141. North America Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 142. North America Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 143. North America Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 144. North America Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 145. North America Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 146. United States Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 147. United States Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 148. United States Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 149. United States Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 150. United States Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 151. Canada Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 152. Canada Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 153. Canada Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 154. Canada Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 155. Canada Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 156. Mexico Biologics Fill and Finish Services, by Type USD Million (2015-2020)
  • Table 157. Mexico Biologics Fill and Finish Services, by Application USD Million (2015-2020)
  • Table 158. Mexico Biologics Fill and Finish Services, by Organization Size USD Million (2015-2020)
  • Table 159. Mexico Biologics Fill and Finish Services, by Filled Types USD Million (2015-2020)
  • Table 160. Mexico Biologics Fill and Finish Services, by Diseases USD Million (2015-2020)
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Biologics Fill and Finish Services: by Type(USD Million)
  • Table 172. Biologics Fill and Finish Services Liquid , by Region USD Million (2021-2026)
  • Table 173. Biologics Fill and Finish Services Lyophilized , by Region USD Million (2021-2026)
  • Table 174. Biologics Fill and Finish Services: by Application(USD Million)
  • Table 175. Biologics Fill and Finish Services Preclinical , by Region USD Million (2021-2026)
  • Table 176. Biologics Fill and Finish Services Clinical , by Region USD Million (2021-2026)
  • Table 177. Biologics Fill and Finish Services Commercial , by Region USD Million (2021-2026)
  • Table 178. Biologics Fill and Finish Services: by Organization Size(USD Million)
  • Table 179. Biologics Fill and Finish Services Small-sized , by Region USD Million (2021-2026)
  • Table 180. Biologics Fill and Finish Services Mid -sized , by Region USD Million (2021-2026)
  • Table 181. Biologics Fill and Finish Services Large / very large , by Region USD Million (2021-2026)
  • Table 182. Biologics Fill and Finish Services: by Filled Types(USD Million)
  • Table 183. Biologics Fill and Finish Services Peptides / proteins , by Region USD Million (2021-2026)
  • Table 184. Biologics Fill and Finish Services Antibodies , by Region USD Million (2021-2026)
  • Table 185. Biologics Fill and Finish Services Vaccines , by Region USD Million (2021-2026)
  • Table 186. Biologics Fill and Finish Services Cell therapies , by Region USD Million (2021-2026)
  • Table 187. Biologics Fill and Finish Services Gene therapies , by Region USD Million (2021-2026)
  • Table 188. Biologics Fill and Finish Services Viral products , by Region USD Million (2021-2026)
  • Table 189. Biologics Fill and Finish Services Oligonucleotides , by Region USD Million (2021-2026)
  • Table 190. Biologics Fill and Finish Services: by Diseases(USD Million)
  • Table 191. Biologics Fill and Finish Services Cancer , by Region USD Million (2021-2026)
  • Table 192. Biologics Fill and Finish Services Infectious diseases , by Region USD Million (2021-2026)
  • Table 193. Biologics Fill and Finish Services Autoimmune diseases , by Region USD Million (2021-2026)
  • Table 194. Biologics Fill and Finish Services Cardiovascular diseases , by Region USD Million (2021-2026)
  • Table 195. Biologics Fill and Finish Services Other indications , by Region USD Million (2021-2026)
  • Table 196. South America Biologics Fill and Finish Services, by Country USD Million (2021-2026)
  • Table 197. South America Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 198. South America Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 199. South America Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 200. South America Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 201. South America Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 202. Brazil Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 203. Brazil Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 204. Brazil Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 205. Brazil Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 206. Brazil Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 207. Argentina Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 208. Argentina Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 209. Argentina Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 210. Argentina Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 211. Argentina Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 212. Rest of South America Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 213. Rest of South America Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 214. Rest of South America Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 215. Rest of South America Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 216. Rest of South America Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 217. Asia Pacific Biologics Fill and Finish Services, by Country USD Million (2021-2026)
  • Table 218. Asia Pacific Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 219. Asia Pacific Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 220. Asia Pacific Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 221. Asia Pacific Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 222. Asia Pacific Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 223. China Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 224. China Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 225. China Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 226. China Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 227. China Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 228. Japan Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 229. Japan Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 230. Japan Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 231. Japan Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 232. Japan Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 233. India Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 234. India Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 235. India Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 236. India Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 237. India Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 238. South Korea Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 239. South Korea Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 240. South Korea Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 241. South Korea Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 242. South Korea Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 243. Taiwan Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 244. Taiwan Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 245. Taiwan Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 246. Taiwan Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 247. Taiwan Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 248. Australia Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 249. Australia Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 250. Australia Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 251. Australia Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 252. Australia Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 253. Rest of Asia-Pacific Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 254. Rest of Asia-Pacific Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 255. Rest of Asia-Pacific Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 256. Rest of Asia-Pacific Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 257. Rest of Asia-Pacific Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 258. Europe Biologics Fill and Finish Services, by Country USD Million (2021-2026)
  • Table 259. Europe Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 260. Europe Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 261. Europe Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 262. Europe Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 263. Europe Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 264. Germany Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 265. Germany Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 266. Germany Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 267. Germany Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 268. Germany Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 269. France Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 270. France Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 271. France Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 272. France Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 273. France Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 274. Italy Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 275. Italy Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 276. Italy Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 277. Italy Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 278. Italy Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 279. United Kingdom Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 280. United Kingdom Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 281. United Kingdom Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 282. United Kingdom Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 283. United Kingdom Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 284. Netherlands Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 285. Netherlands Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 286. Netherlands Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 287. Netherlands Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 288. Netherlands Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 289. Rest of Europe Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 290. Rest of Europe Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 291. Rest of Europe Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 292. Rest of Europe Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 293. Rest of Europe Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 294. MEA Biologics Fill and Finish Services, by Country USD Million (2021-2026)
  • Table 295. MEA Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 296. MEA Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 297. MEA Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 298. MEA Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 299. MEA Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 300. Middle East Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 301. Middle East Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 302. Middle East Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 303. Middle East Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 304. Middle East Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 305. Africa Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 306. Africa Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 307. Africa Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 308. Africa Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 309. Africa Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 310. North America Biologics Fill and Finish Services, by Country USD Million (2021-2026)
  • Table 311. North America Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 312. North America Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 313. North America Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 314. North America Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 315. North America Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 316. United States Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 317. United States Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 318. United States Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 319. United States Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 320. United States Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 321. Canada Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 322. Canada Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 323. Canada Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 324. Canada Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 325. Canada Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 326. Mexico Biologics Fill and Finish Services, by Type USD Million (2021-2026)
  • Table 327. Mexico Biologics Fill and Finish Services, by Application USD Million (2021-2026)
  • Table 328. Mexico Biologics Fill and Finish Services, by Organization Size USD Million (2021-2026)
  • Table 329. Mexico Biologics Fill and Finish Services, by Filled Types USD Million (2021-2026)
  • Table 330. Mexico Biologics Fill and Finish Services, by Diseases USD Million (2021-2026)
  • Table 331. Research Programs/Design for This Report
  • Table 332. Key Data Information from Secondary Sources
  • Table 333. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biologics Fill and Finish Services: by Type USD Million (2015-2020)
  • Figure 5. Global Biologics Fill and Finish Services: by Application USD Million (2015-2020)
  • Figure 6. Global Biologics Fill and Finish Services: by Organization Size USD Million (2015-2020)
  • Figure 7. Global Biologics Fill and Finish Services: by Filled Types USD Million (2015-2020)
  • Figure 8. Global Biologics Fill and Finish Services: by Diseases USD Million (2015-2020)
  • Figure 9. South America Biologics Fill and Finish Services Share (%), by Country
  • Figure 10. Asia Pacific Biologics Fill and Finish Services Share (%), by Country
  • Figure 11. Europe Biologics Fill and Finish Services Share (%), by Country
  • Figure 12. MEA Biologics Fill and Finish Services Share (%), by Country
  • Figure 13. North America Biologics Fill and Finish Services Share (%), by Country
  • Figure 14. Global Biologics Fill and Finish Services share by Players 2020 (%)
  • Figure 15. Global Biologics Fill and Finish Services share by Players (Top 3) 2020(%)
  • Figure 16. Global Biologics Fill and Finish Services share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Becton, Dickson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 19. Becton, Dickson, and Company (United States) Revenue: by Geography 2020
  • Figure 20. Syntegon Technology GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Syntegon Technology GmbH (Germany) Revenue: by Geography 2020
  • Figure 22. IMA Industria Macchine Automatiche S.p.A. (Italy) Revenue, Net Income and Gross profit
  • Figure 23. IMA Industria Macchine Automatiche S.p.A. (Italy) Revenue: by Geography 2020
  • Figure 24. Stevanato Group (Italy) Revenue, Net Income and Gross profit
  • Figure 25. Stevanato Group (Italy) Revenue: by Geography 2020
  • Figure 26. Groninger & Co.gmbh (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Groninger & Co.gmbh (Germany) Revenue: by Geography 2020
  • Figure 28. Gerresheimer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Gerresheimer AG (Germany) Revenue: by Geography 2020
  • Figure 30. SGD Pharma (France) Revenue, Net Income and Gross profit
  • Figure 31. SGD Pharma (France) Revenue: by Geography 2020
  • Figure 32. Bausch Advanced Technologies Group (United States) Revenue, Net Income and Gross profit
  • Figure 33. Bausch Advanced Technologies Group (United States) Revenue: by Geography 2020
  • Figure 34. Vanrx Pharmasystems Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 35. Vanrx Pharmasystems Inc. (Canada) Revenue: by Geography 2020
  • Figure 36. Maquinaria Industrial Dara, SL (Spain) Revenue, Net Income and Gross profit
  • Figure 37. Maquinaria Industrial Dara, SL (Spain) Revenue: by Geography 2020
  • Figure 38. Global Biologics Fill and Finish Services: by Type USD Million (2021-2026)
  • Figure 39. Global Biologics Fill and Finish Services: by Application USD Million (2021-2026)
  • Figure 40. Global Biologics Fill and Finish Services: by Organization Size USD Million (2021-2026)
  • Figure 41. Global Biologics Fill and Finish Services: by Filled Types USD Million (2021-2026)
  • Figure 42. Global Biologics Fill and Finish Services: by Diseases USD Million (2021-2026)
  • Figure 43. South America Biologics Fill and Finish Services Share (%), by Country
  • Figure 44. Asia Pacific Biologics Fill and Finish Services Share (%), by Country
  • Figure 45. Europe Biologics Fill and Finish Services Share (%), by Country
  • Figure 46. MEA Biologics Fill and Finish Services Share (%), by Country
  • Figure 47. North America Biologics Fill and Finish Services Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Becton, Dickson, and Company (United States)
  • Syntegon Technology GmbH (Germany)
  • IMA Industria Macchine Automatiche S.p.A. (Italy)
  • Stevanato Group (Italy)
  • Groninger & Co.gmbh (Germany)
  • Gerresheimer AG (Germany)
  • SGD Pharma (France)
  • Bausch Advanced Technologies Group (United States)
  • Vanrx Pharmasystems Inc. (Canada)
  • Maquinaria Industrial Dara, SL (Spain)
Additional players considered in the study are as follows:
West Pharmaceutical Services, Inc. (United States) , OPTIMA packaging group GmbH (Germany) , Bausch+Strobel (Germany)
Select User Access Type

Key Highlights of Report


Apr 2021 222 Pages 89 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Biologics Fill and Finish Services Quantitative research analysis
Global Biologics Fill and Finish Services Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Biologics Fill and Finish Services market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of Global Biologics Fill and Finish Services market are Becton, Dickson, and Company (United States), Syntegon Technology GmbH (Germany), IMA Industria Macchine Automatiche S.p.A. (Italy), Stevanato Group (Italy), Groninger & Co.gmbh (Germany), Gerresheimer AG (Germany), SGD Pharma (France), Bausch Advanced Technologies Group (United States), Vanrx Pharmasystems Inc. (Canada) and Maquinaria Industrial Dara, SL (Spain), to name a few.
In this highly competitive & fast evolving Biologics Fill and Finish Services industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global Biologics Fill and Finish Services Report?

Have a Query? Click Here

Other Related Reports

Thyroid Disorder Comprehensive Study by Type (Hypothyroidism, Hyperthyroidism, Goiter, Thyroid nodules, Thyroid cancer), Treatment (Homeopathic Treatment, Ayurvedic Treatment, Other (Allelopathy)), E...
$ 3750
Alfuzosin Comprehensive Study by Type (5mg Tablets, 10mg Tablets), Application (Hospital, Drug store) Players and Region - Global Market Outlook to 2025
$ 3500
Mesalamine Comprehensive Study by Type (Capsule, Tablets, Rectal Enema), Application (Hospital, Pharmacies, Medical Stores), Mode of Administration (Oral, Rectal), Dosage (250 mg, 375 mg, 400 mg, 500...
$ 3350
Iron Sucrose Injection Comprehensive Study by Application (Adult, Adolescents, Geriatric, Children), Distribution Channels (Online Pharmacy, Medical Stores, Hospital Pharmacy, Others), End User (Hosp...
$ 3650
Phosphate Binder Comprehensive Study by Type (Calcium Carbonate, Calcium Acetate, Sevelamer Hydrochloride, Lanthanum Carbonate, Magnesium Hydroxide, Sucroferric Oxyhydroxide, Ferric Citrate, Others),...
$ 3650
Milk Thistle Supplement Comprehensive Study by Application (Food Industry, Cosmetic Industry, Pharmaceutical Industry), Form (Capsules, Tablets, Soft gel), Distribution Channel (Hypermarket/Supermark...
$ 3650